Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01662609 · ClinicalTrials.gov registry record
Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer
A clinical trial, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- 90
- Enrollment target
NCT01662609 is a clinical trial that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 90 participants.
The verdict
NCT01662609 has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to find out whether Endoscopic Ultrasound (EUS) can detect early stage pre-cancerous or cancerous changes in the pancreas in patients at high-risk for the development of pancreatic cancer. Endoscopic refers to the use of an instrument called an endoscope - a thin, flexible tube with a tiny video camera and light on the end. Ultrasound refers to an imaging technique that uses sound waves to produce pictures. EUS in this research study is a method of combining endoscopy and ultrasound imaging to obtain high quality images of the pancreas.
Interventions
- PROCEDURE Endoscopic Ultrasound (EUS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2007-08-23 |
| Est. Completion | 2022-08-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01662609
The ClinicalTrials.gov registry entry for NCT01662609 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Endoscopic Ultrasound (EUS) is the first listed.
NCT01662609 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01662609 about?
NCT01662609 is a clinical study titled "Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer". The purpose of this study is to find out whether Endoscopic Ultrasound (EUS) can detect early stage pre-cancerous or cancerous changes in the pancreas in patients at high-risk for the development of pancreatic cancer. Endoscopic refers to the use of an instrument called an endoscope - a thin, flexib...
What is the current status of trial NCT01662609?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2007-08-23. Estimated completion is 2022-08-16.
What interventions are being tested in trial NCT01662609?
The interventions under investigation include: Endoscopic Ultrasound (EUS) (PROCEDURE).
Who is sponsoring clinical trial NCT01662609?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.